Microbiological Quality Control of Pharmaceutical Products

Contamination of pharmaceutical products by objectionable microorganisms is a major risk within the pharmaceutical industry as it may impact product integrity and patient safety. To prevent contamination events from occurring, licensed pharmaceutical manufacturing companies worldwide are required to adhere to strict regulations and robust quality control procedures issued by their respective government agencies. In the following white paper, we discuss the importance of microbiological quality control during the pharmaceutical manufacturing process and guidance on selecting reference strains to support this endeavor.

First Name
Last Name